These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 25762480)

  • 1. Perceptions of Contralateral Breast Cancer Risk: A Prospective, Longitudinal Study.
    Portschy PR; Abbott AM; Burke EE; Nzara R; Marmor S; Kuntz KM; Tuttle TM
    Ann Surg Oncol; 2015 Nov; 22(12):3846-52. PubMed ID: 25762480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceptions of contralateral breast cancer: an overestimation of risk.
    Abbott A; Rueth N; Pappas-Varco S; Kuntz K; Kerr E; Tuttle T
    Ann Surg Oncol; 2011 Oct; 18(11):3129-36. PubMed ID: 21947590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
    Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
    Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer.
    Arrington AK; Jarosek SL; Virnig BA; Habermann EB; Tuttle TM
    Ann Surg Oncol; 2009 Oct; 16(10):2697-704. PubMed ID: 19653045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of patient characteristics and outcomes of contralateral prophylactic mastectomy and unilateral total mastectomy in breast cancer patients.
    Chung A; Huynh K; Lawrence C; Sim MS; Giuliano A
    Ann Surg Oncol; 2012 Aug; 19(8):2600-6. PubMed ID: 22396004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of breast reconstruction on the decision to undergo contralateral prophylactic mastectomy.
    Ashfaq A; McGhan LJ; Pockaj BA; Gray RJ; Bagaria SP; McLaughlin SA; Casey WJ; Rebecca AM; Kreymerman P; Wasif N
    Ann Surg Oncol; 2014 Sep; 21(9):2934-40. PubMed ID: 24756811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contralateral prophylactic mastectomy in an Asian population: a single institution review.
    Sim Y; Tan VK; Ho GH; Wong CY; Madhukumar P; Tan BK; Yong WS; Ng YY; Ong KW
    Breast; 2014 Feb; 23(1):56-62. PubMed ID: 24275318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in contralateral prophylactic mastectomy for unilateral cancer: a report from the National Cancer Data Base, 1998-2007.
    Yao K; Stewart AK; Winchester DJ; Winchester DP
    Ann Surg Oncol; 2010 Oct; 17(10):2554-62. PubMed ID: 20461470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sexual functioning in women after mastectomy versus breast conserving therapy for early-stage breast cancer: a prospective controlled study.
    Aerts L; Christiaens MR; Enzlin P; Neven P; Amant F
    Breast; 2014 Oct; 23(5):629-36. PubMed ID: 25082211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of immediate breast reconstruction and choice for contralateral prophylactic mastectomy.
    Hoskin TL; Hieken TJ; Degnim AC; Jakub JW; Jacobson SR; Boughey JC
    Surgery; 2016 Apr; 159(4):1199-209. PubMed ID: 26704783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Issues of regret in women with contralateral prophylactic mastectomies.
    Montgomery LL; Tran KN; Heelan MC; Van Zee KJ; Massie MJ; Payne DK; Borgen PI
    Ann Surg Oncol; 1999 Sep; 6(6):546-52. PubMed ID: 10493622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 'Taking control of cancer': understanding women's choice for mastectomy.
    Covelli AM; Baxter NN; Fitch MI; McCready DR; Wright FC
    Ann Surg Oncol; 2015 Feb; 22(2):383-91. PubMed ID: 25190120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mastectomy and contralateral prophylactic mastectomy rates: an institutional review.
    Damle S; Teal CB; Lenert JJ; Marshall EC; Pan Q; McSwain AP
    Ann Surg Oncol; 2011 May; 18(5):1356-63. PubMed ID: 21125335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and patient satisfaction of breast conserving therapy for central breast cancer by the B technique.
    Eggemann H; Ignatov A; Elling D; Lampe D; Lantzsch T; Weise M; Costa SD
    Ann Surg Oncol; 2013 Oct; 20(11):3438-45. PubMed ID: 23709056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of contralateral prophylactic mastectomy for prevention of contralateral breast cancer.
    Roberts A; Habibi M; Frick KD
    Ann Surg Oncol; 2014 Jul; 21(7):2209-17. PubMed ID: 24633665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancer.
    Liu Y; Pérez M; Schootman M; Aft RL; Gillanders WE; Ellis MJ; Jeffe DB
    Breast Cancer Res Treat; 2010 Dec; 124(3):835-44. PubMed ID: 20446031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation in Contralateral Prophylactic Mastectomy Rates According to Racial Groups in Young Women with Breast Cancer, 1998 to 2011: A Report from the National Cancer Data Base.
    Grimmer L; Liederbach E; Velasco J; Pesce C; Wang CH; Yao K
    J Am Coll Surg; 2015 Jul; 221(1):187-96. PubMed ID: 26047763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors that influence contralateral prophylactic mastectomy election among women with ductal carcinoma in situ who were evaluated for BRCA genetic testing.
    Elsayegh N; Kuerer HM; Lin H; Gutierrez Barrera AM; Jackson M; Muse KI; Litton JK; Albarracin C; Afrough A; Hortobagyi GN; Arun BK
    Ann Surg Oncol; 2014 Oct; 21(11):3466-72. PubMed ID: 24796968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer.
    Wong SM; Freedman RA; Sagara Y; Aydogan F; Barry WT; Golshan M
    Ann Surg; 2017 Mar; 265(3):581-589. PubMed ID: 28169929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer.
    Jagsi R; Hawley ST; Griffith KA; Janz NK; Kurian AW; Ward KC; Hamilton AS; Morrow M; Katz SJ
    JAMA Surg; 2017 Mar; 152(3):274-282. PubMed ID: 28002555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.